Inactive Instrument
Precision Therapeutics Inc Stock Nasdaq
Stocks
US74033P1003
Biotechnology & Medical Research
| Market Cap | 96.21M 85.73M 79.37M 71.83M 135M 9.08B 137M 952M 373M 4.77B 361M 353M 15.21B | P/E 2026 * |
-4.77x | P/E 2027 * | -75.5x |
|---|---|---|---|---|---|
| Enterprise Value | 96.21M 85.73M 79.37M 71.83M 135M 9.08B 137M 952M 373M 4.77B 361M 353M 15.21B | EV / Sales 2026 * |
1.59x | EV / Sales 2027 * | 0.22x |
| Free-Float |
93.93% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Precision Therapeutics Inc
| 1 day | -7.56% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 09/02/2026 | |
| Director of Finance/CFO | - | 16/04/2026 | |
Kyle Okamoto
PSD | President | - | 01/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Handley
BRD | Director/Board Member | 66 | 19/02/2020 |
Charles Nuzum
CHM | Chairman | 78 | 09/02/2026 |
| Director/Board Member | 60 | 09/07/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -7.56% | -8.33% | - | - | 96.21M | ||
| -0.21% | -6.36% | +49.00% | +74.13% | 66.34B | ||
| -0.22% | +10.10% | +12.77% | +87.32% | 52.92B | ||
| +0.82% | +9.46% | +7.75% | +73.53% | 54.82B | ||
| +3.28% | +5.56% | +26.48% | +50.54% | 44.09B | ||
| +0.51% | +9.94% | +22.39% | +129.02% | 43.72B | ||
| -1.15% | +0.35% | +263.06% | +958.02% | 42.13B | ||
| +0.10% | +9.96% | +17.15% | +59.33% | 33.96B | ||
| -1.30% | -3.61% | +37.37% | +7.16% | 26.17B | ||
| +0.69% | +6.07% | +31.89% | +26.94% | 23.37B | ||
| Average | -0.40% | +4.78% | +51.99% | +162.89% | 43.06B | |
| Weighted average by Cap. | +0.42% | +4.67% | +51.32% | +166.78% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 60.4M 53.82M 49.83M 45.1M 84.96M 5.7B 85.97M 597M 234M 3B 227M 222M 9.55B | 431M 384M 356M 322M 607M 40.7B 614M 4.27B 1.67B 21.39B 1.62B 1.58B 68.17B |
| Net income | -41.4M -36.89M -34.16M -30.91M -58.23M -3.91B -58.92M -410M -161M -2.05B -155M -152M -6.54B | -4.5M -4.01M -3.71M -3.36M -6.33M -425M -6.4M -44.51M -17.47M -223M -16.88M -16.53M -711M |
| Net Debt | - | - |
Employees
-
















